Skip to main content
Premium Trial:

Request an Annual Quote

Ocimum Biosolutions, MWG Biotech, BioGenex

Premium

Ocimum Biosolutions last week introduced OciChips, the microarray portfolio it acquired from MWG Biotech, the company said.

OciChips includes the complete genomes of a multitude of model organisms such as rat and mouse as well as the complete human genome.

The Hyderabad, India-based company will also provide customers with custom arrays and the oligo sets for those who wish to homebrew their microarrays.

Ocimum aquired MWG's hybridization service, catalog arrays, oligo sets, consumable and kits, software, and array user information from MWG for an undisclosed sum in March (see BAN 3/2/2005).


BioGenex last week launched Xmatrx, a system for cell and tissue staining applications, for use in drug research and development, the company said.

The company said that Xmatrx is useful for the development of automated slide-based assays designed to perform microarray hybridizations, in vitro and in situ PCR, DNA sequencing, and the detection of SNPs and micro-deletions.

BioGenex said that digital image analysis could be performed using its BioGenex GenoMx VISION software.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.